Evidence map›Paper›PMID 35550718›Full record

Observational studyRevista espanola de geriatria y gerontologia

Health impact on the elderly survivors of COVID-19: Six months follow up.

Pamela Carrillo-Garcia, Blanca Garmendia-Prieto, Giovanna Cristofori, Isabel Lozano-Montoya, Javier Gómez-Pavón

Abstract readObservational Study
In one paragraph

Observational study in Revista espanola de geriatria y gerontologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Global prevalence of post-COVID-19 condition: a systematic review and meta-analysis of prospective evidence.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Editorial: COVID in Older People: Some Answers, New Questions.The journal of nutrition, health & aging · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pamela Carrillo-GarciaGeriatric Department, Hospital Central de la Cruz Roja, San José y Santa Adela, Madrid, Spain; School of Medicine, Alfonso X El Sabio University, Villanueva de la Cañada, Madrid, Spain. Electronic address: cpamela312@hotmail.com.
Blanca Garmendia-PrietoGeriatric Department, Hospital Central de la Cruz Roja, San José y Santa Adela, Madrid, Spain; School of Medicine, Alfonso X El Sabio University, Villanueva de la Cañada, Madrid, Spain.
Giovanna CristoforiGeriatric Department, Hospital Central de la Cruz Roja, San José y Santa Adela, Madrid, Spain.
Isabel Lozano-MontoyaGeriatric Department, Hospital Central de la Cruz Roja, San José y Santa Adela, Madrid, Spain; School of Medicine, Alfonso X El Sabio University, Villanueva de la Cañada, Madrid, Spain.
Javier Gómez-PavónGeriatric Department, Hospital Central de la Cruz Roja, San José y Santa Adela, Madrid, Spain; School of Medicine, Alfonso X El Sabio University, Villanueva de la Cañada, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo analyse factors associated with mortality at 6 months in survivors older than 70 years after hospital admission for SARS-CoV-2.

methodsDescriptive observational study with follow-up at 6 months. All patients over 70 years of age, discharged from the Hospital Central de la Cruz Roja, after hospitalization for COVID-19 consecutively during the months March to May 2020 were included. The outcome at 6 months (mortality, readmissions) were collected.

resultsA total of 165 patients were included. Mean age 88.5±6.73, women 69.1%. High comorbidity 33.9%. Mean previous Barthel Index was 65.39±33.64 and at discharge 58.12±34.04. 24.2% had severe polypharmacy and 47.9% severe frailty. Six months after hospital discharge, 13% died and 23.8% required at least one readmission. More than half of the sample had some of the following sequelae: dyspnea 20%(33), functional impairment 41.7%(69), cognitive impairment 31.3%(52) or depressive symptoms 42.4%(70). Functional impairment at discharge was associated with an increased risk of mortality (OR 5.33; 95% CI 1.11-25.73).

conclusionsThe functional status was a factor associated with risk of mortality at 6 months.

Indexed as

COVID-19AgedAged, 80 and overFemaleFollow-Up StudiesHospitalizationHumansPatient DischargeSARS-CoV-2SurvivorsCOVID-19Deterioro funcionalFunctional impairmentMortalidadMortalitySupervivienteSurvivors

Identifiers

PMID35550718
PMCPMC9020524

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.